MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DENTSPLY SIRONA Inc. - Common Stock (NQ:XRAY)

8.695 -0.165 (-1.86%)
Delayed Quote Updated: 3:53 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DENTSPLY SIRONA Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
3 Stocks Under $10 Walking a Fine Line
Investors can certainly boost their returns by concentrating on stocks trading between $1 and $10. However, a disciplined approach is necessary because many ... 
Via StockStory
News headline image
Q2 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how dental equipment & tec... 
Via StockStory
News headline image
1 Value Stock with Impressive Fundamentals and 2 Facing Headwinds
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the... 
Via StockStory
News headline image
Robbins Geller Rudman & Dowd LLP Announces Pending Class Action Lawsuit in the Dentsply Securities Litigation
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Dentsply Sirona (NASDAQ:XRAY) Shares Rally 5% After Mixed Q1 Results Beat Revenue Estimates ↗
Via Chartmill
News headline image
3 Russell 2000 Stocks We Steer Clear Of
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
Via StockStory
News headline image
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be... 
Via StockStory
News headline image
1 Stock Under $50 to Research Further and 2 Facing Headwinds
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However... 
Via StockStory
News headline image
3 Unprofitable Stocks with Open Questions
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th... 
Via StockStory
News headline image
Dentsply Sirona (XRAY) Q2 2026 Earnings Call Transcript ↗
Revenue declined 4.1% as restructuring efforts begin to take hold. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q2 Earnings Call
Dentsply Sirona’s second quarter results were met with a negative market reaction, as shares declined following revenue and non-GAAP earnings that exceeded W... 
Via StockStory
Topics Earnings World Trade
News headline image
Why Dentsply Sirona (XRAY) Stock Is Trading Lower Today
What Happened? Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) fell 6.8% in the afternoon session after the company reported second-quarter 2... 
Via StockStory
News headline image
XRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds
Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q2 CY2026, but sales fell by 4.1% year on year to $898 millio... 
Via StockStory
Topics World Trade
News headline image
DENTSPLY SIRONA Q2 Earnings Call Highlights ↗
DENTSPLY SIRONA (NASDAQ:XRAY) reported second-quarter 2026 revenue of $898 million, down 4.1% on a reported basis and 6.3% on a constant-currency basis, as the dental products company continued its... 
Via MarketBeat
Topics Earnings World Trade
News headline image
Dentsply Sirona (NASDAQ:XRAY) Beats Q2 CY2026 Sales Expectations
Dental products company Dentsply Sirona (NASDAQ:XRAY) reported Q2 CY2026 results topping the market’s revenue expectations, but sales fell by 4.1% year on ye... 
Via StockStory
News headline image
Earnings To Watch: Dentsply Sirona (XRAY) Reports Q2 Results Tomorrow
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting results this Thursday after market hours. Here’s what investors should know. Dentsply... 
Via StockStory
News headline image
3 Reasons to Sell XRAY and 1 Stock to Buy Instead
Dentsply Sirona has been treading water for the past six months, recording a small loss of 0.5% while holding steady at $12.66. The stock also fell short of ... 
Via StockStory
News headline image
Dental Equipment & Technology Stocks Q1 In Review: Dentsply Sirona (NASDAQ:XRAY) Vs Peers
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Dentsply Sirona (NASDAQ:XRAY) and i... 
Via StockStory
News headline image
3 Small-Cap Stocks We Think Twice About
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
News headline image
3 Unprofitable Stocks That Fall Short
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv... 
Via StockStory
News headline image
1 Cash-Producing Stock with Exciting Potential and 2 We Avoid
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc... 
Via StockStory
News headline image
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi... 
Via StockStory
Topics Economy
News headline image
The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q1 Earnings Call
Dentsply Sirona’s first quarter results reflected a company in the midst of operational transformation, with revenue holding steady year over year but outper... 
Via StockStory
Topics Earnings World Trade
News headline image
Dentsply Sirona (XRAY) Q1 2026 Earnings Transcript ↗
Dentsply Sirona (XRAY) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
XRAY Q1 Deep Dive: Revenue Flat as Dentsply Sirona Advances Restructuring and Product Initiatives
Dental products company Dentsply Sirona (NASDAQ:XRAY) reported Q1 CY2026 results beating Wall Street’s revenue expectations, but sales were flat year on year... 
Via StockStory
News headline image
Dentsply Sirona (NASDAQ:XRAY) Beats Q1 CY2026 Sales Expectations
Dental products company Dentsply Sirona (NASDAQ:XRAY) announced better-than-expected revenue in Q1 CY2026, but sales were flat year on year at $880 million. ... 
Via StockStory
News headline image
Dentsply Sirona (XRAY) Reports Q1: Everything You Need To Know Ahead Of Earnings
Dental products company Dentsply Sirona (NASDAQ:XRAY) will be reporting results this Tuesday after the bell. Here’s what investors should know. Dentsply Siro... 
Via StockStory
News headline image
Dental Equipment & Technology Stocks Q4 Recap: Benchmarking Dentsply Sirona (NASDAQ:XRAY)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how dental equipment ... 
Via StockStory
News headline image
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session as the reopening of the Strait of Hormuz signaled a cooling of global logistics and energy ... 
Via StockStory
Topics Economy
News headline image
1 Small-Cap Stock with Competitive Advantages and 2 We Avoid
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story